A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.
NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology ...
University of Colorado Denver Biomedical Engineering Associate Professor Chelsea Magin is developing a lung model to help ...
A new inhaled therapy targets ANGPTL4 to reduce lung inflammation, fluid buildup, and scarring after infections. Preclinical ...
In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a ...
A new inhaled therapy targeting lung inflammation shows promise in reducing damage and improving recovery after severe ...
All eyes were on Crown Princess Mette-Marit of Norway during an unexpected family reunion on Friday. The nation’s future ...
Nerandomilast may represent a meaningful addition to the treatment arsenal, offering patients and clinicians a new option for pulmonary fibrosis. A new systematic review and meta-analysis suggests ...
Nanyang Technological University, Singapore (NTU Singapore) is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology company Lipigon Pharmaceuticals AB ...
Father-of-one Evan Wilson missed out of his son’s first Christmas and will likely miss out on his first birthday as well.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results